Skip to main content
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
113.16
-0.84 (-0.74%)
At close: Mar 28, 2025, 4:00 PM
112.00
-1.16 (-1.03%)
Pre-market: Mar 31, 2025, 8:51 AM EDT

Neurocrine Biosciences Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Ingrezza
2.31B 2.20B 2.07B 1.93B 1.84B 1.74B 1.63B 1.54B
Ingrezza Growth
26.00% 26.72% 27.42% 25.79% 28.59% 30.49% 31.14% 32.96%
Collaboration and Other
24.70M 26.20M 27.70M 27.70M 26.50M 25.90M 27.50M 47.30M
Collaboration and Other Growth
-6.79% 1.16% 0.73% -41.44% -44.56% -47.03% -42.11% 8.99%
Ongentys and Other Products
17.20M 18.00M 20.40M 22.70M 24.60M 23.00M 19.80M 15.60M
Ongentys and Other Products Growth
-30.08% -21.74% 3.03% 45.51% 87.79% 125.49% 106.25% 69.57%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.